Ho Jin Yi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ho Jin Yi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Ae Woo
College of Pharmacy, Graduate School of Applied Science and Technology for Skin Health and Aesthetics, Ewha Womans University, Seoul, 120-750, Republic of Korea; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 120-750, Republic of Korea
2 shared publications - Byung-Hoon Lee
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea
1 shared publication - Goo Taeg Oh
Heart-Immune-Brain Network Research Center, Department of Life Science, Ewha Womans University, Seoul, 03760, Republic of Korea
1 shared publication - Ji Won Park
College of Pharmacy and Research, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea
1 shared publication - Jiyoung Park
College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea
1 shared publication - Juhyun Sim
National Forensic Service, 26460, 10 Ipchun-ro, Wonju, Gangwon-do, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Elsevier in Redox Biology
- Vol. 93, 104176
Peroxiredoxin Ⅲ safeguards cardiac function against doxorubicin by regulating mitochondrial quality control via H2O2 detoxification
- 17 April 2026
- Published by Elsevier in Redox Biology
- Vol. 93, 104176
Open AccessPeroxiredoxin Ⅲ safeguards cardiac function against doxorubicin by regulating mitochondrial quality control via H2O2 detoxification
- Open Access
- 2 October 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 225, 236-246
Cisplatin induces kidney damage through the down-regulation of Prx I by autophagic degradation
- 2 October 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 225, 236-246
Open AccessCisplatin induces kidney damage through the down-regulation of Prx I by autophagic degradation